XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2018 $ 11,392   $ 0 $ (5,563) $ 10,963 $ 6,593   $ (601)
Balance (in shares) at Dec. 31, 2018     1,192 429        
Components of comprehensive income:                
Net income 447         447    
Other comprehensive income (loss) (1)             (1)
Issuance of common stock pursuant to employee stock options 30       30      
Issuance of common stock pursuant to employee stock options (in shares)     2          
Issuance of common stock pursuant to restricted stock units 0              
Issuance of common stock pursuant to restricted stock units (in shares)     2          
Restricted stock surrendered for employees’ tax liability (45)       (45)      
Restricted stock surrendered for employees' tax liability (in shares)     (1)          
Share-based compensation expense related to employee stock options and restricted stock units 56       56      
Dividends ($0.41 and $0.37 per common share) (283)         (283)    
Ending balance at Mar. 31, 2019 11,596   $ 0 $ (5,563) 11,004 6,757   (602)
Balance (in shares) at Mar. 31, 2019     1,195 429        
Beginning balance at Dec. 31, 2018 11,392   $ 0 $ (5,563) 10,963 6,593   (601)
Balance (in shares) at Dec. 31, 2018     1,192 429        
Components of comprehensive income:                
Net income 978              
Other comprehensive income (loss) (6)              
Ending balance at Sep. 30, 2019 12,235   $ 0 $ (5,563) 11,116 7,289   (607)
Balance (in shares) at Sep. 30, 2019     1,197 429        
Beginning balance at Mar. 31, 2019 11,596   $ 0 $ (5,563) 11,004 6,757   (602)
Balance (in shares) at Mar. 31, 2019     1,195 429        
Components of comprehensive income:                
Net income 328         328    
Other comprehensive income (loss) (6)             (6)
Issuance of common stock pursuant to employee stock options 28       28      
Issuance of common stock pursuant to employee stock options (in shares)     1          
Restricted stock surrendered for employees’ tax liability (4)       (4)      
Share-based compensation expense related to employee stock options and restricted stock units 35       35      
Ending balance at Jun. 30, 2019 11,977   $ 0 $ (5,563) 11,063 7,085   (608)
Balance (in shares) at Jun. 30, 2019     1,196 429        
Components of comprehensive income:                
Net income 204         204    
Other comprehensive income (loss) 1             1
Issuance of common stock pursuant to employee stock options 29       29      
Issuance of common stock pursuant to employee stock options (in shares)     1          
Restricted stock surrendered for employees’ tax liability (8)       (8)      
Share-based compensation expense related to employee stock options and restricted stock units 32       32      
Ending balance at Sep. 30, 2019 12,235   $ 0 $ (5,563) 11,116 7,289   (607)
Balance (in shares) at Sep. 30, 2019     1,197 429        
Beginning balance at Dec. 31, 2019 12,805 $ (3) $ 0 $ (5,563) 11,174 7,813 $ (3) (619)
Balance (in shares) at Dec. 31, 2019     1,197 429        
Components of comprehensive income:                
Net income 505         505    
Other comprehensive income (loss) (9)             (9)
Issuance of common stock pursuant to employee stock options 27       27      
Issuance of common stock pursuant to employee stock options (in shares)     1          
Issuance of common stock pursuant to restricted stock units 0              
Issuance of common stock pursuant to restricted stock units (in shares)     1          
Restricted stock surrendered for employees’ tax liability (31)       (31)      
Share-based compensation expense related to employee stock options and restricted stock units 43       43      
Dividends ($0.41 and $0.37 per common share) (316)         (316)    
Ending balance at Mar. 31, 2020 13,021   $ 0 $ (5,563) 11,213 7,999   (628)
Balance (in shares) at Mar. 31, 2020     1,199 429        
Beginning balance at Dec. 31, 2019 12,805 $ (3) $ 0 $ (5,563) 11,174 7,813 $ (3) (619)
Balance (in shares) at Dec. 31, 2019     1,197 429        
Components of comprehensive income:                
Net income 1,688              
Other comprehensive income (loss) (14)              
Ending balance at Sep. 30, 2020 14,382   $ 0 $ (5,563) 11,395 9,183   (633)
Balance (in shares) at Sep. 30, 2020     1,201 429        
Beginning balance at Mar. 31, 2020 13,021   $ 0 $ (5,563) 11,213 7,999   (628)
Balance (in shares) at Mar. 31, 2020     1,199 429        
Components of comprehensive income:                
Net income 580         580    
Other comprehensive income (loss) (6)             (6)
Issuance of common stock pursuant to employee stock options 44       44      
Issuance of common stock pursuant to employee stock options (in shares)     1          
Restricted stock surrendered for employees’ tax liability (3)       (3)      
Share-based compensation expense related to employee stock options and restricted stock units 46       46      
Ending balance at Jun. 30, 2020 13,682   $ 0 $ (5,563) 11,300 8,579   (634)
Balance (in shares) at Jun. 30, 2020     1,200 429        
Components of comprehensive income:                
Net income 604         604    
Other comprehensive income (loss) 1             1
Issuance of common stock pursuant to employee stock options 43       43      
Issuance of common stock pursuant to employee stock options (in shares)     1          
Restricted stock surrendered for employees’ tax liability (6)       (6)      
Share-based compensation expense related to employee stock options and restricted stock units 58       58      
Ending balance at Sep. 30, 2020 $ 14,382   $ 0 $ (5,563) $ 11,395 $ 9,183   $ (633)
Balance (in shares) at Sep. 30, 2020     1,201 429